Advertisement

Topics

Latest "UCOPIA Communications" News Stories

19:31 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "UCOPIA Communications" found in our extensive news archives from over 250 global news sources.

More Information about UCOPIA Communications on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about UCOPIA Communications for you to read. Along with our medical data and news we also list UCOPIA Communications Clinical Trials, which are updated daily. BioPortfolio also has a large database of UCOPIA Communications Companies for you to search.

Showing "UCOPIA Communications" News Articles 1–25 of 1,400+

Tuesday 25th September 2018

MorphoSys Announces its Licensee Janssen has Initiated a Phase 3 Trial (PROTOSTAR) to Evaluate Guselkumab in Pediatric Psoriasis Patients (news with additional features)

DGAP-News: MorphoSys AG / Key word(s): Study 25.09.2018 / 22:01 The issuer is solely responsible for the content of this announcement. Planegg/Munich, Germany, September 25, 2018   MorphoSys Announces its Licensee Janssen has Initiated a Phase 3 Trial (PROTOSTAR) to Evaluate Guselkumab in Pediatric Psoriasis Patients   MorphoSys AG (FSE: MOR; Prime Standard Segment, MD...


Freedom Innovations Expands its Hydraulic Ankle Technology to K2 Space with Kintrol Launch

Freedom Innovations has launched the Kintrol Hydraulic Ankle/Foot system, combining advanced Kinterra hydraulic ankle technology with the highest quality, aerospace-grade fiberglass to provide K2 level ambulators the comfort and control they demand. K2 ambulators are prosthetic users who are typically defined as having the ability or potential for...

AniCell Biotech Implemented MRPeasy Manufacturing Software to Achieve Complete Visibility of Business Data and Prepare for Growth

AniCell Biotech has completed implementing MRPEasy manufacturing resource planning software for the manufacturing of their veterinary regenerative medicine products. CHANDLER, Ariz. (PRWEB) September 25, 2018 AniCell Biotech has completed implementing MRPEasy manufacturing resource planning software for the manufacturing of their veterinary regenerative medicine products. Key buying decisions: 1...


Klick Health’s Incubated Startup, Circulation, Announces Successful Exit

Agency’s commercialization practice thriving as it continues to introducenew healthcare innovation and modern business models Klick Health’s growing commercialization partner portfolio is proud of the successful exit of Circulation, one of Klick’s first incubation initiatives. Circulation has

Zoetis Named a Top Company for Working Mothers

Zoetis recognized by Working Mother Magazine for its career advancement opportunities, female representation, work-life programs, and health and wellness benefits Roni Thebo named Zoetis’ 2018 Working Mother of the Year Zoetis Inc. (NYSE:ZTS) today announced that it has been named one of Working Mother Magazi...

Scientist.com Adds Experienced Drug Hunter Mark Herbert to Management Team

Pharmaceutical outsourcing marketplace adds Chief Business Officer to oversee company’s rapid worldwide expansion Scientist.com, the life science industry’s leading online marketplace for outsourced research, announced today the appointment of Mark Herbert to its senior leadership team. As the company’s chief business officer, he will focus on co...

Ducon Infratechnologies Provides FGD Market Update

Ducon Infratechnologies Limited (BSE:534674, NSE:DUCON), (“Ducon Infratechnologies”) announced today that the Company has been actively submitting new proposals for Flue Gas Desulfurization (FGD) systems for power plants and industrial boilers. The Company has been proactive in revising earlier submitted proposals and attending technical review meeting...

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines Keele, Darlington and London, 25 September 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, today announced a collaboration with the Centre for Process Innovation (CPI), a UK-based techno...

Terveystalo Plc: Juha Tuominen, Chief Medical Officer of Terveystalo leaves the company

Terveystalo Plc Stock Exchange release 25 September 2018 at 9:00 a.m. EEST Juha Tuominen (Professor, MD, Ph.D), Chief Medical Officer of Terveystalo since 2009, has been elected as the new Managing Director of Hospital District of Helsinki and Uusimaa, starting from 1 January 2019. Terveystalo has started the search for the successor of Mr. Tuominen. Unto Palonen, senior physician of oc...

Monday 24th September 2018

Okayama University Research: Insights Into Mechanisms Governing the Resistance to the ...

OKAYAMA, Japan, September 25, 2018 /PRNewswire/ -- Okayama University researchers report in Biochemical and Biophysical Research Communications that the anti-cancer drug cetuximab is released with Read more...

Built-in sound amplifier helps male mosquitoes find females

(University College London) The ears of male mosquitoes amplify the sound of an approaching female using a self-generated phantom tone that mimics the female's wingbeats, which increases the ear's acoustic input by a factor of up to 45,000, finds a new UCL-led study published in Nature Communications.

Promising novel treatment against Alzheimer disease

(McGill University) New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model. Importantly, this drug has already proven to be non-toxic for humans in a clinical setting and could, therefore, be brought quickly to trials in humans against AD. These findings...

FabFitFun Launches “FFF Live” With Interactive Lifestyle Programming

Daily Shows will Feature Product Highlights, Beauty Demos, DIY Projects, Games, and More Leading women’s lifestyle brand FabFitFun announced the launch of “FFF Live,” a new slate of programming airing every day between 11 a.m. and 1 p.m. PT. The programming, featuring product showcases, beauty demonstrations, DIY projects and a gameshow, w...

ComPsych® Corp. Announces 2018 Health at WorkSM Award Winners: Comcast NBCUniversal, NBA, City of Mesa, Fresenius Medical Care North America, Montgomery County, Council on Foreign Relations and Nuru International

ComPsych announced today winners of its 14th-annual Health at Work Awards, honoring organizations that support employees with exceptional wellness and well-being programs. ComPsych Corporation is the world’s largest provider of employee assistance programs and is the pioneer and worldwide leader of fully integrated EAP, behavioral health, wellness, ...

CURE® Media Group Launches #MoreThanAPatient Campaign

Social media campaign highlights how individuals with cancer are more than just a patient. CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, launched #MoreThanAPatient social media campaign on Sept. 24. The campaign features individuals who are telling the public how they are a pa...

Annual Florida Telehealth Summit to be Held in St. Pete Beach on November 7-9

The summit's agenda will include a range of topics pertaining to telehealth practices in the state of Florida. WAYCROSS, Ga. (PRWEB) September 24, 2018 The Southeastern Telehealth Resource Center and nonprofit telehealth networking agency Global Partnership for Telehealth will host the Fifth Annual Florida Telehealth Summit at the TradeWinds Island Grand Resort in St. Pete Beach, Florida. The...

Good Neighbor Pharmacy Receives “Highest in Customer Satisfaction with Chain Drug Store Pharmacies” from J.D. Power

Today, Good Neighbor Pharmacy – a national independent pharmacy network offered through AmerisourceBergen – announced that it has been ranked “Highest in Customer Satisfaction with Chain Drug Store Pharmacies” in the 

City Partners with Operation Lifesaver to Launch Rail Safety Program

Media are invited to attend the launch of a national railway safety-awareness program in partnership with Operation Lifesaver. London is the second Canadian municipality to participate in this new community rail-safety program aimed at curbing tragic railway incidents. We will unveil the first installation of the "Look. Listen. Live" decal, ...

Acquired Immunotherapy Resistance through Transcriptional Repression

The recent flood of immunotherapeutic drugs onto the market has given new hope to many afflicted with cancer. However, while harnessing the immune system to treat cancer shows great promise in some patients, for many, the response does not last long-term. Now, investigators at the Fred Hutchinson Cancer Research Center are studying why some cancers become resistant to immunotherapies, as well as u...

Tailwind Capital Closes Fund III with $1.8 Billion of Commitments

Tailwind Capital (“Tailwind”), a middle market private equity firm investing in targeted sectors within healthcare, business services and industrial services, has closed Tailwind Capital Partners III, L.P. (together with its related funds, “Fund III” or the “Fund”) at $1.8 billion of commitments. The Fund exceeded its initial target and was ove...

University of Electro-Communications eBulletin: Elucidating Mechanisms of Voluntary Control of ...

TOKYO, September 24, 2018 /PRNewswire/ -- University of Electro-Communications (UEC) publishes the September 2018 issue of the UEC e-Bulletin that includes short video profiles of Read more...

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

• First-to-market cell line-derived reference standard for myeloid blood cancers • Largest cell-line derived reference standard available, contains 22 mutations across 19 oncology-relevant genes • Enables faster, more reliable and more cost-effective assay validation Cambridge, UK, 24 September, 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “t...

Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients

Mechelen, Belgium, September 24 2018, 07.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) reports first dosing in the global ROCCELLA Phase 2 trial with GLPG1972/S201086 in knee osteoarthritis patients. Galapagos receives a €9 million milestone payment from its collaboration partner Servier for this achievement. ROCCELLA is a multiregional, randomized, double-blind, placebo-co...

Sunday 23rd September 2018

Antimalarial drug boosted with chemo medicines

Scientists from The University of Melbourne have found a way to boost the efficacy of the world’s most powerful antimalarial drug with the help of chemotherapy medicines, in a breakthrough that may hold the key to overcoming antimalarial drug resistance. Malaria claims the lives of about 450,000 people worldwide every year. Resistance to antimalarial drug artemisinin has already developed in So...

Saturday 22nd September 2018

HP Agilent 8924E CDMA RF Communications Analyzer 30MHz-1000MHz, Tested GOOD

C $387.45 (0 Bids)End Date: Thursday Sep-27-2018 15:24:12 EDTBid now | Add to watch list Biotech365 : HP Agilent 8924E CDMA RF Communications Analyzer 30MHz-1000MHz, Tested GOOD BioMarketplace You want to propose your products or a Biotech Company, a Biotech … Continue reading → Cet article HP Agilent 8924E CDMA RF Communications Analyzer 30MHz-1000MHz, Tested GOOD est apparu en p...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks